Clinical Trial Update: Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/phase 2 clinical trial evaluating sequential high-dose chemotherapy for children with high-risk medulloblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: High-risk Medulloblastoma | Phase 1, Phase 2 | Status: TERMINATED